Results 81 to 90 of about 9,772,737 (279)

Task Force 9: Drugs and performance-enhancing substances

open access: yesJournal of the American College of Cardiology, 2005
Athletes commonly use drugs and dietary supplements because they hope to improve athletic performance. These performance-enhancing substances include ergogenic and thermogenic supplements, stimulants, anabolic steroids, peptide hormones, and others.
Estes, N.A. Mark   +3 more
openaire   +2 more sources

Investigating transcription factor dynamics in health and disease using FRAP

open access: yesFEBS Letters, EarlyView.
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj   +3 more
wiley   +1 more source

Conserved binding mode but diverse interfaces of MreC‐PBP2 interactions

open access: yesFEBS Letters, EarlyView.
The crystal structure of abMreC reveals a conserved two β‐barrel architecture and provides structural insights into its role within the bacterial elongasome. The abMreC–abPBP2 complex model identifies the molecular basis of MreC‐mediated PBP2 recognition, contributing to the regulation of peptidoglycan synthesis.
Hyunseok Jang   +4 more
wiley   +1 more source

THE FREQUENCY OF MISUSE IN EGYPTIAN GYMNASIUMS FOR PERFORMANCE-ENHANCING PURPOSES: A TOXICOLOGICAL AND FORENSIC PERSPECTIVE CROSS-SECTIONAL STUDY [PDF]

open access: yesThe Egyptian Journal of Forensic Sciences and Applied Toxicology
Background: The misuse of over-the-counter (OTC) and prescription medications for performance-enhancing purposes is a growing concern in gym settings globally, including Egypt. These substances, including anabolic-androgenic steroids (AAS) and stimulants,
Mokhtar Fathy Abdel-satar   +2 more
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

open access: yesFEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta   +3 more
wiley   +1 more source

An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes

open access: yesFEBS Letters, EarlyView.
GPR35 generates two functionally distinct isoforms with previously unresolved roles. GPR35‐short mediates immune‐cell chemotaxis, while GPR35‐long is enriched in colorectal cancer epithelium, where it supports increased metabolism, proliferation, and tumor‐associated transcriptional programs.
Jørgen D. Rønneberg   +14 more
wiley   +1 more source

NPS, PEDs and other emerging drugs on the Clearnet and the Darkweb: Use in sport

open access: yesEmerging Trends in Drugs, Addictions, and Health
The aim of the project was to identify new performance enhancing drugs (PEDs) including novel psychoactive substances (NPS) both in the Darkweb as well as in the Clearnet that could be offered to athletes to improve their performance.Searches on the ...
Irene Mazzoni, Olivier Rabin
doaj   +1 more source

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila

open access: yesFEBS Letters, EarlyView.
Animals must match their growth rate to available nutrients. We show that in Drosophila larvae, the nutrient‐sensing TOR kinase controls growth by regulating levels of TFAM, a key regulator of mitochondrial function, in the adipose tissue. When nutrients are abundant, high TOR activity suppresses TFAM, lowering mitochondrial bioenergetic activity and ...
Shrivani Sriskanthadevan‐Pirahas   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy